Emerald Advisers’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $4.64M | Sell |
|
|||||
|
2017
Q1 | $13.2M | Sell |
|
|||||
|
2016
Q4 | $12.2M | Buy |
|
|||||
|
2016
Q3 | $13M | Buy |
|
|||||
|
2016
Q2 | $11.3M | Sell |
|
|||||
|
2016
Q1 | $12.4M | Buy |
|
|||||
|
2015
Q4 | $17.2M | Buy |
|
|||||
|
2015
Q3 | $10.6M | Sell |
|
|||||
|
2015
Q2 | $22.2M | Buy |
|
|||||
|
2015
Q1 | $17.5M | Sell |
|
|||||
|
2014
Q4 | $12.1M | Buy |
|
|||||
|
2014
Q3 | $5.24M | Buy |
|
|||||
|
2014
Q2 | $3.56M | Buy |
|
|||||
|
2014
Q1 | $3.84M | Buy |
|